Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Executive Briefing Series (formerly The Food & Drug Letter) > GAO Investigation Sought Into NECC, Congressional Probe Heats Up

Executive Briefing Series (formerly The Food & Drug Letter)

Nov. 2, 2012

GAO Investigation Sought Into NECC, Congressional Probe Heats Up

Two House Democrats have asked the Government Accountability Office (GAO) to investigate the compounding pharmacy industry to look for gaps in federal and state oversight.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives

Related Articles

The Buzz FDA Studying Composite Score Effect On DTC Marketing FDA Hydrocodone Decision Delay Reflects Enforcement, Access Tensions Biosimilar Interchangeability Battle Moves to California

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.